Authors


Kristen Coppock, MA, Editor

Latest:

16 New Investigators Awarded AACP Grants

Sixteen new investigator award (NIA) winners are receiving up to $10,000 in grants from the American Association of Colleges of Pharmacy.


Eric Wu, PhD

Latest:

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.



Terry McInnis, MD, MPH

Latest:

Medication Underuse: The Most Underappreciated Quality-of-Care Gap

A patient-centric approach to medications is the key to identifying drug therapy problems.


Aaron Berger, PMP

Latest:

Maintaining Compliance in the Global Pharmacovigilance Landscape

A satisfactory system for the collection and reporting of adverse events is increasingly important as manufacturers place additional requirements on their specialty pharmacy and health care provider partners, and these needs go beyond the United States.


Homa Dastani, PhD

Latest:

Impact of Patient Cost Sharing on Multiple Sclerosis Treatment

This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.


Jeffrey Fudin, PharmD, DAIPM, FCCP, FASHP, FFSMB

Latest:

Pharmacists Can Help Assess New FDA-Approved IV Opioid

Oliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.



Jeffrey Kosowsky, MD, PhD

Latest:

The Potential for Telehealth Within the Pharmacy Space

Telehealth is a cost-saving solution that uses telecommunications technologies to expand health care outside the walls of a retail pharmacy while complementing and enhancing existing retail pharmacy services.


Brittany Hoffman-Eubanks, PharmD, MBA

Latest:

The Role of Pharmacy Benefit Mangers in American Health Care: Pharmacy Concerns and Perspectives - Part 2

American pharmacies across the nation are struggling as a result of pharmacy benefit manager (PBM) practices.


April Teitelbaum, MD

Latest:

Costs Associated With Second-Line Therapies for Lung Cancer

Erlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.


Mark McCoy, PharmD, MBA

Latest:

Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine Devices

This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.



Sara Dixon, PharmD Candidate 2001

Latest:

Pharmacist Oversupply: Outlook for Students

Pharmacy students are sharing thoughts about the prospective job market and pharmacist oversupply.


Ryan Burke, PharmD

Latest:

Pharmacy Technicians Serving on State Boards: Expanding Roles and Shaping the Future

Increased technician involvement also improves patient care nationwide.


Soim Kim, PharmD Candidate

Latest:

Pregnancy and Lactation Labeling

This article details what pharmacists need to know about the FDA's new proposed rule on pregnancy and lactation labeling.


Pierre Ndje, PharmD

Latest:

Opioid Overdose and Naloxone Delivery Devices in the Community Setting

Although naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.



Tony Dao, PharmD, CPHIMS, CSSBB, LSSBB, PMC HI

Latest:

Who Owns Patients’ Data?

The bigger question is how patients can use that information to positively affect their lives.


David J. Harrison, PhD

Latest:

Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis

For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.


John Meehan, PharmD, MSPBA Candidate

Latest:

What Differentiates Effective Core Services from Enhanced Services in Specialty Pharmacy?

Specialty pharmacies have multiple decisions to make for clinical programs that accompany a contract with a manufacturer.


John Choi, PharmD Candidate

Latest:

The Winding Paths of Pharmacy

Throughout their years in pharmacy school, almost all students have been asked, “What do you want to do after graduation?”



Steven A. Scott, PharmD, RPh

Latest:

"In Your Element": Finding the Right Pharmacy Career

I have just begun my 41st year as a pharmacy educator, and I can truthfully admit that I enjoy what I do as much as or more today than at any other time during my professional career.


Yasmin Grace, PharmD

Latest:

The Evolving Treatment Landscape in Heart Failure: Applying Pharmacists in the Hospital and Retail Setting

This Continuing Education activity is supported by educational funding provided by Amgen and Novartis Pharmaceuticals Inc.


This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned

Latest:

Trends in the 2012 Eisai Oncology Digest: Insurance and Cost Obstacles in Cancer Treatment

Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.


Adam J. Fein, PhD

Latest:

7 Reasons Why Specialty Drug Dispensing Will Boom

Competition is heating up in the specialty marketplace as investment capital is drawn in and the pharmaceutical industry shifts from traditional brand-name drugs to specialty drugs over the next few years.


Michael R. Hess

Latest:

Use Asembia to Take Stock Before Going to Market

Asembia is great not only for networking conversations that can lead to transactions but also for taking stock of your organization.



Saira A. Jan, PharmD, MS

Latest:

Impact of Medicare Part D on Utilization and Expenditures

Examination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.